The Production of Reactive Oxygen and Halogen Species by Neutrophils in Response to Monomeric Forms of Myeloperoxidase


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

It was shown for the first time that myeloperoxidase, a homodimer that consists of two disulfidebonded identical protomers and catalyzes the formation of hypochlorous acid (HOCl), is decomposed by HOCl into monomers (MPO-Cl). Dimeric myeloperoxidase can also be converted into monomers (hemimyeloperoxidase) by reduction of the disulfide bond. In this study, the effects of two monomeric forms of myeloperoxidase, MPO-Cl and hemi-myeloperoxidase, and native dimeric myeloperoxidase on the production of reactive oxygen (O2 and H2O2) and halogen (HOCl) species by neutrophils were compared. Neutrophil production of these species was monitored after addition of hemi-myeloperoxidase, MPO-Cl, or dimeric myeloperoxidase and also after the subsequent addition of activators, phorbol-12-myristate-13-acetate or N-formyl-Met-Leu-Phe. HOCl production was assessed by chemiluminescence in the presence of luminol; O2 production was assessed by chemiluminescence in the presence of lucigenin and by cytochrome c reduction determined spectrophotometrically, and H2O2 production was measured using fluorimetry with scopoletin. The results indicate that MPO-Cl and hemi-myeloperoxidase, which can occur in blood under halogenative stress, do not prime neutrophil NADPH oxidase, and do not enhance the production of reactive oxygen (O2 and H2O2) and halogen (HOCl) species.

About the authors

I. V. Gorudko

Belarusian State University

Email: o-panas@mail.ru
Belarus, Minsk, 220030

E. V. Mikhalchik

Federal Research and Clinical Center of Physical-Chemical Medicine

Email: o-panas@mail.ru
Russian Federation, Moscow, 119435

A. V. Sokolov

Federal Research and Clinical Center of Physical-Chemical Medicine; Institute of Experimental Medicine; St. Petersburg State University; Center of Preclinical Translational Research

Email: o-panas@mail.ru
Russian Federation, Moscow, 119435; St. Petersburg, 197376; St. Petersburg, 199034; St. Petersburg, 197371

D. V. Grigorieva

Belarusian State University

Email: o-panas@mail.ru
Belarus, Minsk, 220030

V. A. Kostevich

Federal Research and Clinical Center of Physical-Chemical Medicine; Institute of Experimental Medicine

Email: o-panas@mail.ru
Russian Federation, Moscow, 119435; St. Petersburg, 197376

V. B. Vasilyev

Institute of Experimental Medicine; St. Petersburg State University

Email: o-panas@mail.ru
Russian Federation, St. Petersburg, 197376; St. Petersburg, 199034

S. N. Cherenkevich

Belarusian State University

Email: o-panas@mail.ru
Belarus, Minsk, 220030

O. M. Panasenko

Federal Research and Clinical Center of Physical-Chemical Medicine

Author for correspondence.
Email: o-panas@mail.ru
Russian Federation, Moscow, 119435

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2017 Pleiades Publishing, Inc.